Schroder Investment Management Group’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,356
Closed -$83K 1348
2017
Q1
$83K Hold
1,356
﹤0.01% 1151
2016
Q4
$99K Sell
1,356
-5,551
-80% -$361K ﹤0.01% 1062
2016
Q3
$413K Sell
6,907
-4,493
-39% -$286K ﹤0.01% 987
2016
Q2
$718K Sell
11,400
-600
-5% -$38.7K ﹤0.01% 944
2016
Q1
$748K Buy
12,000
+6,820
+132% +$402K ﹤0.01% 945
2015
Q4
$304K Buy
5,180
+2,980
+135% +$169K ﹤0.01% 1017
2015
Q3
$119K Sell
2,200
-500
-19% -$27.3K ﹤0.01% 1053
2015
Q2
$159K Hold
2,700
﹤0.01% 1055
2015
Q1
$161K Buy
2,700
+2,100
+350% +$123K ﹤0.01% 1083
2014
Q4
$36K Buy
+600
New +$33.2K ﹤0.01% 1219
2014
Q1
Sell
-200
Closed -$11.4K 1521
2013
Q4
$11.4K Hold
200
﹤0.01% 1432
2013
Q3
$11.9K Hold
200
﹤0.01% 1446
2013
Q2
$10.9K Buy
+200
New +$9.41K ﹤0.01% 1413

Other funds holding UTMD

Schroder Investment Management Group's UTMD Position: Q2 2017 in Review

Schroder Investment Management Group sold out of Utah Medical Products (UTMD) in Q2 2017, closing a stake of 1,356 shares — an estimated $83K sold.

Schroder Investment Management Group first reported a position in UTMD in Q2 2013 and held it in 13 quarters. The position peaked at $748K in Q1 2016. 76 funds tracked by Wall St. Rank hold UTMD as of Q2 2017.

  • Schroder Investment Management Group reported no remaining Utah Medical Products position as of Q2 2017 after selling out during the quarter.
  • Schroder Investment Management Group sold 1,356 Utah Medical Products shares in Q2 2017, an estimated $83K.
  • Schroder Investment Management Group first reported a position in Utah Medical Products in Q2 2013 and held it in 13 quarters.
  • Schroder Investment Management Group's Utah Medical Products position peaked at $748K in Q1 2016.
  • 76 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2017.

Based on Schroder Investment Management Group's 13F filing for Q2 2017, filed 10 Aug 2017.